Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 51 Neoplasms 34 Colorectal Neoplasms 23 Lung Neoplasms 17 Prostatic Neoplasms 16 Melanoma 15 Neoplastic Cells, Circulating 13 Pancreatic Neoplasms 11 Multiple Myeloma 11 Uterine Cervical Neoplasms 10 Ovarian Neoplasms 10 Carcinoma, Non-Small-Cell Lung 8 Papillomavirus Infections 7 Neoplasm Metastasis 7 Leukemia, Myeloid, Acute 7 Colonic Neoplasms 7 Lymphoma, Follicular 6 Lymphoma 6 Hematologic Neoplasms 6 Uveal Melanoma 5 Sarcoma 5 Head and Neck Neoplasms 5 Glioma 5 Uterine Cervical Dysplasia 4 Urinary Bladder Neoplasms 4 Rectal Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Glioblastoma 4 Disease 4 COVID-19 4

Interventions

Vasopressins 1 Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization 1 Saline Solution 1 Norepinephrine 1 Methylene Blue 1 Contraceptives, Oral 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Shock, Septic × Blood Specimen Collection × Clear all

NCT01600989 2014-04-25

MitoSepsis

Insel Gruppe AG, University Hospital Bern

Shock, Septic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡